| 12/5/2024 | BK | Market Commentary: Hexion, Calpine, Bright Horizons, Starwood, Waystar, Travel + Leisure and more break
|
| 12/2/2024 | BK | Market Commentary: Dechra updated; Culligan, Vistra, BrightSpring, CQP, Innio, Starwood and many more set talk
|
| 6/6/2024 | BK | Market Commentary: Resonetics, Solenis, Enlyte, Citco, WCG, White Cap, Acrisure, PCI, Idera and more break
|
| 6/5/2024 | CLHY | Market Commentary: Harbor, Titan, Altium, Vaco, CQP, AOC break; Brookfield, Ineos, Amynta and more revised
|
| 6/4/2024 | CLHY | Market Commentary: Ecovyst breaks, Acrisure, Novaria, CQP revised; Harbor, PCI, Amynta, Medline accelerated
|
| 4/1/2024 | BK | S&P revises Amynta outlook to positive
|
| 12/18/2023 | CLHY | Market Commentary: McAfee Enterprise first-lien softens post-downgrade; Amynta steady; NEP allocates euro loan
|
| 12/18/2023 | BK | Market Commentary: McAfee Enterprise first-lien softens post-downgrade; Amynta steady; NEP allocates euro loan
|
| 12/11/2023 | BK | Market Commentary: IntraFi sets final terms; Chobani accelerated; Castlelake, Playa and more disclose talk
|
| 2/7/2023 | CLHY | Market Commentary: Inspire Brands, American Airlines accelerate deadlines; Asurion, Amynta disclose talk
|
| 2/6/2023 | BK | S&P assigns B- to Amynta loans
|
| 1/15/2021 | BK | S&P revises Amynta view to stable
|
| 2/20/2019 | BK | S&P affirms Amynta on add-on
|
